Posted on FB:
National Centre for Neuroimmunology and Emerging Diseases - NCNED
A turning point for CFS/ME Research
NCNED have announced that a pivotal research publication has been accepted: ‘Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients’. This article proves a significant impairment in TRPM3 function in NK cells and that TRPM3 function is significantly compromised in CFS/ME patients. NCNED used the ‘gold standard’ of patch-clamp electrophys...iology to demonstrate this world-first discovery.
NCNED used NK cells as a model for all cells in the body expressing this essential calcium ion channel. TRPM3 calcium ion channels are widely distributed in numerous body systems such as the central nervous system, metabolic and endocrine systems (particularly regulating pancreas and insulin function), cardiovascular system, gastrointestinal system, skeletomuscular system and immune system.
NCNED are now pursuing additional TRPs they have previously identified in CFS/ME patients and are accelerating drug investigations for pharmaco-therapeutic applications in CFS/ME patients.
We particularly wish to acknowledge the support of Stafford Fox Medical Research Foundation, Mr Douglas Stutt, the Mason Foundation, the Alison Hunter Memorial Foundation, the Blake Beckett Foundation, McCusker Charitable Foundation, Buxton Foundation, Change for ME Charity, Qld ME/CFS/FM Support Association Qld Inc. and the ACT ME/Chronic Fatigue Syndrome Society.
Reference: Cabanas H, Muraki K, Eaton N, Balinas C, Staines D and Marshall-Gradisnik S: Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients, Molecular Medicine, Accepted 2018.
Best wishes
Sonya, Don and the NCNED team